U.S. markets closed

Nutriband Inc. (NTRB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
10.70-0.81 (-7.04%)
At close: 3:59PM EST

Nutriband Inc.

121 South Orange Avenue
Suite 1500
Orlando, FL 32801
United States
407 377 6695
http://nutriband.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Sean GallagherExec. Chairman & PresN/AN/A1963
Mr. Gareth SheridanCEO & Director57kN/A1990
Dr. Jeffrey PatrickChief Scientific Officer & Head of Scientific Advisory BoardN/AN/A1970
Mr. Gerald GoodmanCFO & Chief Accounting OfficerN/AN/A1948
Dr. Alan SmithCOO & Pres of 4P TherapeuticsN/AN/A1966
Mr. Patrick RyanChief Technical OfficerN/AN/A1987
Dr. Larry M. DillahaChief Medical Officer & Member of Scientific Advisory BoardN/AN/A1964
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS patch line; a sleep patch line; and a nausea and motion sickness patch line. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Corporate Governance

Nutriband Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.